Serpatinib (serpatinib) mechanism of action

Selpatinib (Serpatinib) is a highly effective and innovative targeted therapy designed to combat cancers withRET gene fusions or mutations. The unique mechanism of action of this drug brings new breakthroughs in the field of cancer treatment. Seputinib is used in adults to treat certain types ofnon-small cell lung cancer. Seputinib is also used in adults and children at least 2 years old to treat certain types ofthyroid cancer.

Seputinib is an orally bioavailable, selective inhibitor of wild-type, mutant and fusion products involving proto-oncogene receptor tyrosine kinase (RET) rearranged during transfection, with potential anti-tumor activity. Following oral administration, Seputinib selectively binds to and targets various RET mutants and RET-containing fusion products. This results in inhibition of cell growth in tumor cells that exhibit increased RET activity. RET overexpression, activating mutations, and fusions lead to upregulation and/or overactivation of RET tyrosine kinase activity in various cancer cell types; dysregulation of RET activity plays a critical role in the development and progression of these cancers.

It is worth mentioning that the high selectivity of seputinib enables it to hit targets more accurately and reduce damage to normal cells. This greatly improves the safety and tolerability of the treatment.

Although Seputinib is already on the market in China, unfortunately, its reimbursement is not covered by medical insurance. The version sold in China is 80 mg and 56 capsules, and the price is about 15,000 yuan. In addition, original and generic serpatinib are also sold in overseas markets, and the original version is expensive. If necessary, patients can purchase the original version of Seputinib directly from domestic hospital pharmacies. At the same time, a generic version of serpatinib is also available in Laos. The specification is 40 mg and 120 tablets, and the price is about more than 4,000 yuan. If you have further questions about Seputinib, please consult a professional overseas medical consultant.

In summary, seputinib exerts anti-tumor effects by inhibitingRET kinase activity, providing a new treatment strategy for cancer patients with RET gene fusions or mutations. As the mechanism of action of this drug is further studied, we can expect to see more cancer patients benefit from it in the future.